Jihwan You
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jihwan You has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Kyum-Yil Kwon
Department of Neurology, Soonchunhyang University Seoul Hospital, Seoul, Korea
3 shared publications - Rae On Kim
Department of Neurology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea
2 shared publications - Eun Ji Lee
Department of Neurology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea
1 shared publication - Geunhyung Gye
Department of Neurology, Soonchunhyang University Seoul Hospital, Soonchunhyang University School of Medicine, Seoul, Korea
1 shared publication - Ilsoo Kim
Department of Neurology and Parkinson’s disease Centre, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
1 shared publication - Jaehyun Yoon
Department of Neurology, Soonchunhyang University Seoul Hospital, Soonchunhyang University School of Medicine, Seoul, Korea
1 shared publication
Latest Publications
- Open Access
- 21 January 2026
- Published by IMR Press in Revista De Neurologia
- Vol. 81 (1) , 39115
Clinical Characteristics of Geriatric Patients With de novo Parkinson’s Disease Compared with the Non-Geriatric Population: Adapting to Changes in the Era of Aging
Background: Parkinson’s disease (PD) is increasingly being diagnosed in older adults. Despite this trend, the clinical features of geriatric patients with PD are not thoroughly defined. This study aimed to compare the clinical characteristics of geriatric patients (aged ≥75 years) with de novo PD against those of non-geriatric patients (aged <75 years) newly diagnosed with PD. Methods: This retrospective analysis enrolled 110 patients aged 50 years or older with de novo PD from our hospital’s Parkinsonism registry between 2017 and 2023. Clinical evaluations included motor assessment via the Unified Parkinson’s Disease Rating Scale Part III and global cognitive function was measured using the Montreal Cognitive Assessment (MoCA). Nonmotor symptoms, including depression, anxiety, and fatigue, were assessed using other scales and autonomic dysfunction was assessed using the Scale for Outcomes in Parkinson’s Disease–Autonomic (SCOPA-AUT). Results: Geriatric patients with PD (n = 37) exhibited significantly lower cognitive performance (lower MoCA scores, p < 0.001) and more pronounced autonomic dysfunction (higher SCOPA-AUT scores, p = 0.0103) in comparison with non-geriatric PD patients (n = 73). In multivariate logistic regression analysis, lower MoCA scores (odds ratio [OR]: 0.7642, 95% confidence interval [CI]: 0.6712–0.8701, p < 0.001) and elevated SCOPA-AUT scores (OR: 1.0640, 95% CI: 1.0031–1.1286, p = 0.0391) emerged as significant independent predictors of geriatric PD. Conclusions: These findings reveal a distinct clinical phenotype among geriatric patients with de novo PD, underscoring the value of early detection and proactive management of cognitive and autonomic impairments in this group. The results further emphasize the need for individualized assessment and therapeutic interventions tailored to the specific requirements of geriatric patients with PD.
- 21 January 2026
- Published by IMR Press in Revista De Neurologia
- Vol. 81 (1) , 39115
Open AccessClinical Characteristics of Geriatric Patients With de novo Parkinson’s Disease Compared with the Non-Geriatric Population: Adapting to Changes in the Era of Aging
Background: Parkinson’s disease (PD) is increasingly being diagnosed in older adults. Despite this trend, the clinical features of geriatric patients with PD are not thoroughly defined. This study aimed to compare the clinical characteristics of geriatric patients (aged ≥75 years) with de novo PD against those of non-geriatric patients (aged <75 years) newly diagnosed with PD. Methods: This retrospective analysis enrolled 110 patients aged 50 years or older with de novo PD from our hospital’s Parkinsonism registry between 2017 and 2023. Clinical evaluations included motor assessment via the Unified Parkinson’s Disease Rating Scale Part III and global cognitive function was measured using the Montreal Cognitive Assessment (MoCA). Nonmotor symptoms, including depression, anxiety, and fatigue, were assessed using other scales and autonomic dysfunction was assessed using the Scale for Outcomes in Parkinson’s Disease–Autonomic (SCOPA-AUT). Results: Geriatric patients with PD (n = 37) exhibited significantly lower cognitive performance (lower MoCA scores, p < 0.001) and more pronounced autonomic dysfunction (higher SCOPA-AUT scores, p = 0.0103) in comparison with non-geriatric PD patients (n = 73). In multivariate logistic regression analysis, lower MoCA scores (odds ratio [OR]: 0.7642, 95% confidence interval [CI]: 0.6712–0.8701, p < 0.001) and elevated SCOPA-AUT scores (OR: 1.0640, 95% CI: 1.0031–1.1286, p = 0.0391) emerged as significant independent predictors of geriatric PD. Conclusions: These findings reveal a distinct clinical phenotype among geriatric patients with de novo PD, underscoring the value of early detection and proactive management of cognitive and autonomic impairments in this group. The results further emphasize the need for individualized assessment and therapeutic interventions tailored to the specific requirements of geriatric patients with PD.
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Clinical Neurology
- Vol. 22 (3) , 375-377
Early Suspected Progressive Supranuclear Palsy–Cerebellar Type From MRI and Dopaminergic Imaging in a Patient Initially Presenting With Ataxia
You J, et al. J Clin Neurol. 2026 ;22:e40. https://doi.org/10.3988/jcn.2025.0584
- 1 January 2026
- Published by XMLink in Journal of Clinical Neurology
- Vol. 22 (3) , 375-377
Open AccessEarly Suspected Progressive Supranuclear Palsy–Cerebellar Type From MRI and Dopaminergic Imaging in a Patient Initially Presenting With Ataxia
You J, et al. J Clin Neurol. 2026 ;22:e40. https://doi.org/10.3988/jcn.2025.0584
- Open Access
- 1 January 2024
- Published by XMLink in Journal of Clinical Neurology
- Vol. 20 (2) , 201-207
Association Between Baseline Gait Parameters and Future Fall Risk in Patients With De Novo Parkinson’s Disease: Forward Versus Backward Gait
Kwon KY, et al. J Clin Neurol. 2024 Jan;20:e1. https://doi.org/10.3988/jcn.2022.0299
- 1 January 2024
- Published by XMLink in Journal of Clinical Neurology
- Vol. 20 (2) , 201-207
Open AccessAssociation Between Baseline Gait Parameters and Future Fall Risk in Patients With De Novo Parkinson’s Disease: Forward Versus Backward Gait
Kwon KY, et al. J Clin Neurol. 2024 Jan;20:e1. https://doi.org/10.3988/jcn.2022.0299